Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07417891 · ClinicalTrials.gov registry record · NA

Ketogenic Diet to Reduce Osteoarthritis Pain in MCI

A NA study, sponsored by University of Kansas Medical Center.

Not yet
Registry status
NA
Development phase
10
Enrollment target

NCT07417891: Clinical Trial NA study, sponsored by University of Kansas Medical Center.

NCT07417891 is a NA study that has not yet begun recruiting, run by University of Kansas Medical Center. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07417891, a NA study, has not yet begun recruiting, sponsored by University of Kansas Medical Center.

NOT YET RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Osteoarthritis and mild cognitive impairment are common conditions that share underlying biological processes related to metabolism and inflammation. This study will examine whether a well-formulated ketogenic diet influences pain, physical function, and cognitive outcomes in adults with osteoarthritis and mild cognitive impairment. Participants will follow a supervised ketogenic dietary intervention, with assessments conducted before and after the intervention to evaluate changes in symptoms and related biological markers. The goal of this study is to better understand shared mechanisms between joint pain and cognitive health and to explore whether a ketogenic dietary approach may support symptom management in these populations.

Primary Outcome

Patient- and caregiver-reported outcome. 0-10 with higher scores reflecting worse pain.

Interventions

  • OTHER Well-formulated ketogenic diet

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-06-01
Est. Completion 2027-06-01
Phase NA
University of Kansas Medical Center

408 total trials

What is known before NCT07417891 opens enrollment

NCT07417891 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Well-formulated ketogenic diet is the first listed.

NCT07417891 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07417891 about?

NCT07417891 is a clinical study titled "Ketogenic Diet to Reduce Osteoarthritis Pain in MCI". Osteoarthritis and mild cognitive impairment are common conditions that share underlying biological processes related to metabolism and inflammation. This study will examine whether a well-formulated ketogenic diet influences pain, physical function, and cognitive outcomes in adults with osteoarthri...

What is the current status of trial NCT07417891?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-06-01. Estimated completion is 2027-06-01.

What interventions are being tested in trial NCT07417891?

The interventions under investigation include: Well-formulated ketogenic diet (OTHER).

Who is sponsoring clinical trial NCT07417891?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07417891's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07417891, the US trial registry maintained by the National Library of Medicine. NCT07417891 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.